Dual Renin-Angiotensin System Blockade in Heart Failure

Regulatory authorities decreed that the benefits outweighed the risks sufficiently to lead to worldwide approval of this combination for symptomatic patients with chronic heart failure and a low left ventricular ejection fraction, with appropriate monitoring to minimize adverse effects (6).

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2009-07, Vol.54 (3), p.278-278
Hauptverfasser:	McMurray, John J.V., MD, Granger, Christopher B., MD, Östergren, Jan, MD, PhD, Yusuf, Salim, MB, DPhil, Pfeffer, Marc A., MD, PhD, Swedberg, Karl, MD, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	ACE inhibitors Angiotensin II Type 1 Receptor Blockers - therapeutic use Angiotensin-Converting Enzyme Inhibitors - therapeutic use Cardiac and Cardiovascular Systems Cardiology Cardiovascular Drug therapy Heart failure Heart Failure - drug therapy Humans Internal Medicine Kardiologi Renin-Angiotensin System - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Regulatory authorities decreed that the benefits outweighed the risks sufficiently to lead to worldwide approval of this combination for symptomatic patients with chronic heart failure and a low left ventricular ejection fraction, with appropriate monitoring to minimize adverse effects (6).
ISSN:	0735-1097 1558-3597 1558-3597
DOI:	10.1016/j.jacc.2009.02.073